Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients

Diabetes Care

Volumn 35, Issue 7, 2012, Pages 1429-1435

  Bozzetto, Lutgarda ^a   Prinster, Anna ^b   Annuzzi, Giovanni ^a   Costagliola, Lucia ^a   Mangione, Anna ^a   Vitelli, Alessandra ^a   Mazzarella, Raffaella ^a   Longobardo, Margaret ^a   Mancini, Marcello ^b   Vigorito, Carlo ^a   Riccardi, Gabriele ^a   Rivellese, Angela A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; MONOUNSATURATED FATTY ACID;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE DIET; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FAT CONTENT; FAT INTAKE; FATTY LIVER; FEMALE; GLYCEMIC INDEX; HIGH FIBER DIET; HUMAN; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PHYSICAL ACTIVITY; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RISK REDUCTION; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; EXERCISE; FATS; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; METFORMIN; MIDDLE AGED;

EID: 84862885081     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0033     Document Type: Article

References (40)

1. Bozzetto L, Prinster A, Mancini M, et al. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution. Eur J Clin Invest 2011;41:39-44
2. Kotronen A, Juurinen L, Hakkarainen A, et al. Liver fat is increased in type 2 diabetic patients and underestimated by serum alanine aminotransferase compared with equally obese nondiabetic subjects. Diabetes Care 2008;31:165-169
3. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80 (Pubitemid 20075105)
4. Targher G, Bertolini L, Poli F, et al. Non-alcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005;54:3541-3546 (Pubitemid 43334347)
5. Adiels M, Taskinen MR, Borén J. Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep 2008;8:60-64 (Pubitemid 351384877)
6. Kotronen A, Seppälä-Lindroos A, Bergholm R, Yki-Järvinen H. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome. Diabetologia 2008;51:130-138 (Pubitemid 50003448)
7. Kelley DE, Kuller LH, McKolanis TM, Harper P, Mancino J, Kalhan S. Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care 2004;27:33-40 (Pubitemid 38196706)
8. Bantle JP, Wylie-Rosett J, Albright AL, et al.; American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl 1):S61-S78
9. Marwick TH, Hordern MD, Miller T, et al.; Council on Clinical Cardiology, American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Nutrition, Physical Activity, and Metabolism; Interdisciplinary Council on Quality of Care and Outcomes Research. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:3244-3262
10. Vitola BE, Deivanayagam S, Stein RI, et al. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity (Silver Spring) 2009;17:1744-1748
11. Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005; 100:1072-1081 (Pubitemid 40769044)
12. Westerbacka J, Lammi K, Häkkinen AM, et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005;90:2804-2809 (Pubitemid 40686327)
13. Allard JP, Aghdassi E, Mohammed S, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J Hepatol 2008;48:300-307
14. Gerhard GT, Ahmann A, Meeuws K, McMurry MP, Duell PB, Connor WE. Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am J Clin Nutr 2004;80:668-673 (Pubitemid 41115532)
15. Valtueña S, Pellegrini N, Ardigò D, et al. Dietary glycemic index and liver steatosis. Am J Clin Nutr 2006;84:136-142; quiz 268-269
16. Zelber-Sagi S, Ratziu V, Oren R. Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence. World J Gastroenterol 2011;17:3377-3389
17. Tamura Y, Tanaka Y, Sato F, et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 2005;90:3191-3196 (Pubitemid 41014274)
18. Johnson NA, Sachinwalla T, Walton DW, et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009;50:1105-1112
19. Hallsworth K, Fattakhova G, Hollingsworth KG, et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011;60:1278-1283
20. Carnovale E, Marletta L, Miuccio F. Tabelle di Composizione Degli Alimenti. Roma, Istituto Nazionale della Nutrizione, 1995
21. Richardson MT, Ainsworth BE, Jacobs DR, Leon AS. Validation of the Stanford 7-day recall to assess habitual physical activity. Ann Epidemiol 2001;11:145-153 (Pubitemid 32054781)
22. Provencher SW. Automatic quantitation of localized in vivo 1Hspectra with LCModel. NMR Biomed 2001;14:260-264 (Pubitemid 32611437)
23. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5:281-285
24. 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Invest Radiol 1993;28:297-302
25. Carlson K. Lipoprotein fractionation. J Clin Pathol Suppl (Assoc Clin Pathol) 1973;5: 32-37
26. Ferramosca A, Savy V, Zara V. Olive oil increases the hepatic triacylglycerol content in mice by a distinct influence on the synthesis and oxidation of fatty acids. Biosci Biotechnol Biochem 2008;72:62-69 (Pubitemid 351158965)
27. Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N. Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol 2007;13:361-368 (Pubitemid 46178969)
28. DeLany JP, Windhauser MM, Champagne CM, Bray GA. Differential oxidation of individual dietary fatty acids in humans. Am J Clin Nutr 2000;72:905-911
29. Rivellese AA, Giacco R, Annuzzi G, et al. Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes. Clin Nutr 2008;27:133-141 (Pubitemid 351201850)
30. Bessesen DH, Vensor SH, Jackman MR. Trafficking of dietary oleic, linolenic, and stearic acids in fasted or fed lean rats. Am J Physiol Endocrinol Metab 2000;278: E1124-E1132 (Pubitemid 30439151)
31. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56: 1960-1968 (Pubitemid 47195815)
32. Sanyal AJ, Chalasani N, Kowdley KV, et al.; NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 2010;362:1675-1685
33. Lavine JE, Schwimmer JB, Van Natta ML, et al.; Nonalcoholic Steatohepatitis Clinical Research Network. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011;305:1659-1668
34. Scribner KB, Pawlak DB, Ludwig DS. Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. Obesity (Silver Spring) 2007;15:2190-2199 (Pubitemid 350004086)
35. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 1999;104:1087-1096 (Pubitemid 29536319)
36. Hudgins LC, Seidman CE, Diakun J, Hirsch J. Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am J Clin Nutr 1998;67: 631-639 (Pubitemid 28153165)
37. Musso G, Gambino R, Cassader M. Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders. Curr Opin Lipidol 2010; 21:76-83
38. Yasari S, Prud'homme D, Tesson F, et al. Effects of exercise training on molecular markers of lipogenesis and lipid partitioning in fructose-induced liver fat accumulation. J Nutr Metab. 10 August 2011 [Epub ahead of print]
39. Burns N, Finucane FM, Hatunic M, et al. Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 2007;50:1500-1508 (Pubitemid 46878998)
40. Poirier P, Tremblay A, Broderick T, Catellier C, Tancrède G, Nadeau A. Impact of moderate aerobic exercise training on insulin sensitivity in type 2 diabetic men treated with oral hypoglycemic agents: is insulin sensitivity enhanced only in nonobese subjects? Med Sci Monit 2002; 8:CR59-CR65 (Pubitemid 34218458)